<DOC>
	<DOCNO>NCT00555178</DOCNO>
	<brief_summary>Polymorphic light eruption ( PLE ) photodermatosis extremely high prevalence , particularly among young woman ( 20 % ) . The disease characterize itchy skin lesion sun-exposed body sit occur sun exposure mostly spring early summer . Its etiopathogenesis unknown resistance UV-induced immunosuppression subsequent immune reaction skin photoneoantigens suggest . Regulatory T cell ( CD4+CD25+FoxP3+ ) ( Tregs ) , subset T helper cell , crucial induction immunosuppression . We test hypothesis PLE patient show pathogenic fluctuating Treg level function relate parameter season year , possibly responsible lack immune modulation autoimmunity PLE . Natural medical photohardening may normalize Treg deficiency PLE lead clinical adaption summer . Better insight pathogenesis PLE may give clue develop new therapeutic strategy .</brief_summary>
	<brief_title>Regulatory T Cells ( Tregs ) Polymorphic Light Eruption</brief_title>
	<detailed_description>PLE patient recruit Photodermatology Unit Department Dermatology , Medical University Graz , Graz , Austria . Eligible patient identify diagnosis-related computer-assisted search electronic patient chart system Unit . The diagnosis PLE verify patient 's history , clinical symptom , histologic finding , laboratory study and/or phototesting procedure . The level function Tregs , memory T cell , neutrophil , mast cell , Langerhans cell , cytokine chemokine profile , vitamin D level blood and/or skin study PLE patient compare control group . Volunteers four group enrol study : ) patient PLE undergo preventive medical UV photohardening spring ; ii ) PLE patient undergo preventive UV photohardening ; iii ) healthy control subject ; iv ) patient disease ( include psoriasis , atopic dermatitis , condition ) undergo therapeutic phototherapy . Blood take venous puncture ( mainly cubital vein ) individual study participant four define time point year : ( ) spring ( March April ) ( medical photohardening PLE patient ) ; ( ii ) spring/early summer ( April June ) ( immediately medical photohardening PLE patient ) ; ( iii ) late summer ( August September ) ; ( iv ) late fall ( November December ) . In addition , optional skin biopsy take study parameter list . The statistical power analysis ( alpha 0.05 ; power 0.8 ; assume difference Treg level/function 30 % among group ; base data Myara et al. , 2005 ) reveal 23 patient ( 21+2 expect drop-outs ) need enrol per patient group . All patient non-PLE group sex- age ( plus/minus 5 year ) -matched PLE subject .</detailed_description>
	<mesh_term>Psoriasis</mesh_term>
	<mesh_term>Exanthema</mesh_term>
	<mesh_term>Dermatitis , Atopic</mesh_term>
	<mesh_term>Dermatitis , Contact</mesh_term>
	<criteria>Age 18 year Patients confirm PLE diagnosis either typical anamnesis and/or typical histology lesion and/or positive phototesting result ( group 1 2 ) ; healthy subject ( group 3 ) ; patient phototherapyresponsive disease ( include psoriasis , atopic dermatitis , condition ( group 4 ) . Good general health status Presence history malignant skin tumor Dysplastic melanocytic nevus syndrome Certain photosensitive disorder ( include porphyria , chronic actinic dermatitis , Xeroderma pigmentosum , basal cell nevus syndrome ) Autoimmune disease ( lupus erythematodes , scleroderma , dermatomyositis ) Systemic treatment steroid and/or immunosuppressive drug within last 6 month Antinuclear antibody ( dsDNA , Ro , La ) Firstdegree relatives PLE patient ( exclusion criterion group 3 4 Pregnancy breastfeed Ongoing plan specific hyposensitization treatment ( i.e . specific immunotherapy )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>Polymorphic light eruption</keyword>
	<keyword>Regulatory T cell ( Tregs )</keyword>
	<keyword>Seasonal fluctuation</keyword>
	<keyword>UV radiation</keyword>
	<keyword>Phototherapy</keyword>
</DOC>